AAAAAA

   
Results: 1-11 |
Results: 11
CLOZAPINE-INDUCED ELECTROENCEPHALOGRAM CHANGES AS A FUNCTION OF CLOZAPINE SERUM LEVELS
Authors: FREUDENREICH O WEINER RD MCEVOY JP
Citation: O. Freudenreich et al., CLOZAPINE-INDUCED ELECTROENCEPHALOGRAM CHANGES AS A FUNCTION OF CLOZAPINE SERUM LEVELS, Biological psychiatry, 42(2), 1997, pp. 132-137
A DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING CLOZAPINE TREATMENT WITHIN3 DISTINCT SERUM LEVEL RANGES IN PATIENTS WITH REFRACTORY CHRONIC-SCHIZOPHRENIA
Authors: MCEVOY JP VANDERZWAAG C MCGEE M FREUDENREICH O WILSON WH COOPER TB
Citation: Jp. Mcevoy et al., A DOUBLE-BLIND, RANDOMIZED TRIAL COMPARING CLOZAPINE TREATMENT WITHIN3 DISTINCT SERUM LEVEL RANGES IN PATIENTS WITH REFRACTORY CHRONIC-SCHIZOPHRENIA, Schizophrenia research, 18(2-3), 1996, pp. 8-8
CLOZAPINE-INDUCED EEG CHANGES AS A FUNCTION OF CLOZAPINE SERUM LEVELS
Authors: MCEVOY JP FREUDENREICH O WEINER RD
Citation: Jp. Mcevoy et al., CLOZAPINE-INDUCED EEG CHANGES AS A FUNCTION OF CLOZAPINE SERUM LEVELS, Schizophrenia research, 18(2-3), 1996, p.
MONITORING OF CLOZAPINE BLOOD-LEVELS IN THE REAL-WORLD
Authors: FREUDENREICH O MCEVOY JP COOPER TB
Citation: O. Freudenreich et al., MONITORING OF CLOZAPINE BLOOD-LEVELS IN THE REAL-WORLD, Journal of clinical psychopharmacology, 16(1), 1996, pp. 90-91
PALINACOUSIS AFTER CLOSED-HEAD INJURY IN A PATIENT WITH SCHIZOPHRENIA
Authors: FREUDENREICH O MCEVOY JP
Citation: O. Freudenreich et Jp. Mcevoy, PALINACOUSIS AFTER CLOSED-HEAD INJURY IN A PATIENT WITH SCHIZOPHRENIA, Journal of clinical psychopharmacology, 16(1), 1996, pp. 94-94
RESPONSE OF PATIENTS WITH TREATMENT-REFRACTORY SCHIZOPHRENIA TO CLOZAPINE WITHIN 3 SERUM LEVEL RANGES
Authors: VANDERZWAAG C MCGEE M MCEVOY JP FREUDENREICH O WILSON WH COOPER TB
Citation: C. Vanderzwaag et al., RESPONSE OF PATIENTS WITH TREATMENT-REFRACTORY SCHIZOPHRENIA TO CLOZAPINE WITHIN 3 SERUM LEVEL RANGES, The American journal of psychiatry, 153(12), 1996, pp. 1579-1584
HALOPERIDOL INCREASES SMOKING IN PATIENTS WITH SCHIZOPHRENIA
Authors: MCEVOY JP FREUDENREICH O LEVIN ED ROSE JE
Citation: Jp. Mcevoy et al., HALOPERIDOL INCREASES SMOKING IN PATIENTS WITH SCHIZOPHRENIA, Psychopharmacology, 119(1), 1995, pp. 124-126
HOW MUCH HALDOL-D DOES LARRY REALLY NEED
Authors: FREUDENREICH O MCEVOY JP
Citation: O. Freudenreich et Jp. Mcevoy, HOW MUCH HALDOL-D DOES LARRY REALLY NEED, The Journal of clinical psychiatry, 56(7), 1995, pp. 331-332
ADDED AMANTADINE MAY DIMINISH TARDIVE-DYSKINESIA IN PATIENTS REQUIRING CONTINUED NEUROLEPTICS
Authors: FREUDENREICH O MCEVOY JP
Citation: O. Freudenreich et Jp. Mcevoy, ADDED AMANTADINE MAY DIMINISH TARDIVE-DYSKINESIA IN PATIENTS REQUIRING CONTINUED NEUROLEPTICS, The Journal of clinical psychiatry, 56(4), 1995, pp. 173-173
INSIGHT IN SCHIZOPHRENIA AND MANIA
Authors: SWANSON CL FREUDENREICH O MCEVOY JP NELSON L KAMARAJU L WILSON WH
Citation: Cl. Swanson et al., INSIGHT IN SCHIZOPHRENIA AND MANIA, The Journal of nervous and mental disease, 183(12), 1995, pp. 752-755
CLOZAPINE DECREASES SMOKING IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA
Authors: MCEVOY J FREUDENREICH O MCGEE M VANDERZWAAG C LEVIN E ROSE J
Citation: J. Mcevoy et al., CLOZAPINE DECREASES SMOKING IN PATIENTS WITH CHRONIC-SCHIZOPHRENIA, Biological psychiatry, 37(8), 1995, pp. 550-552
Risultati: 1-11 |